Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1858-2025

C-RAD POSITIONING AB recalls Brand Name: Catalyst+ Product Name: C4D software used in conjunction with Catal…

C-RAD POSITIONING ABUppsala, SwedenReported Jun 4, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

Software issue with scanning equipment that can results in the filed rotation not being applied correctly.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Brand Name: Catalyst+ Product Name: C4D software used in conjunction with Catalyst (SP001-0025), Catalyst HD (SP001-0026), Catalyst PT (SP001-0027), Catalyst X4 (SP002-0035), Catalyst+ (SP003-0001), Catalyst+ HD (SP003-0002), Catalyst+ PT (SP003-0008), Catalyst+ X4, (SPOO3-0009) Product Description: Patient positioning device, diagnostic imaging/radiotherapy, laser Component: Not a component

Lot / code information

UDI
07350005280024; Catalyst HD- SP001-0026/
UDI
07350005280024; Catalyst PT- SP001-0027/
UDI
07350005280024; Catalyst X4- SP002-0035/
UDI
07350005280024; Catalyst+ -
REF
SP003-0001/
UDI
17350005280762 Catalyst+ HD- SP003-0002/
UDI
17350005280779 Catalyst+ PT- SP003-0008/
UDI
17350005280793 Catalyst+ X4 - SP003-0009/
UDI
17350005280809

What the firm is doing

On April 22, 2025, C-RAD Positioning AB issued a Field Safety Notice to affected consignees via E-Mail. C-RAD asked consignees to take the following actions: 1. As an immediate action, the affected users are recommended to: - Do not use Site Groups for treatment plans containing non-coplanar fields. - Ungroup all existing Site Groups. 2. Ensure that all the staff operating the Catalyst family systems and the c4D software application are aware of this information. 3. All customers are requested to reply to C-RAD using the attached FSN Customer Reply Form .

DistributionShow details

Worldwide - US Nationwide distribution in the states of AK, FL, WA, VA, WA, NC, IL, AR, NC and the countries of Germany, Italy, Uzbekistan, South Korea, Vietnam, Austria, Australia, China, Estonia, Belgium, Uzbekistan.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls